Efficacy and safety of the first made in Russia alpha, beta long-acting adrenoblocker proxodolol in patients with arterial hypertension of the second degree

Aim. To study efficacy and safety of a new dose and dosage form of proxodolol - a beta-adrenoblocker with alpha1-adrenoblocking activity - in patients with moderate arterial hypertension (AH). Material and methods. A total of 60 patients with verified diagnosis of essential AH of the second degree w...

Full description

Bibliographic Details
Main Author: S A Belyaeva
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2011-04-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/30848
_version_ 1818326585423429632
author S A Belyaeva
S A Belyaeva
author_facet S A Belyaeva
S A Belyaeva
author_sort S A Belyaeva
collection DOAJ
description Aim. To study efficacy and safety of a new dose and dosage form of proxodolol - a beta-adrenoblocker with alpha1-adrenoblocking activity - in patients with moderate arterial hypertension (AH). Material and methods. A total of 60 patients with verified diagnosis of essential AH of the second degree were randomized into two groups: group 1 (n = 40) received proxodolol, group 2 (n = 20) was given carvedilol. The trial lasted for 89 days. Results. The trial demonstrates that proxodolol is highly effective and safe in the treatment of AH. Conclusion. Proxodolol is effective and safe in hypertension, in a dose 120 mg its activity is the same as carvedilol in a dose 25 mg.
first_indexed 2024-12-13T12:02:43Z
format Article
id doaj.art-ac5025f8cf2a48c3b7ef48674c34eb86
institution Directory Open Access Journal
issn 0040-3660
2309-5342
language Russian
last_indexed 2024-12-13T12:02:43Z
publishDate 2011-04-01
publisher "Consilium Medicum" Publishing house
record_format Article
series Терапевтический архив
spelling doaj.art-ac5025f8cf2a48c3b7ef48674c34eb862022-12-21T23:47:03Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422011-04-01834525527864Efficacy and safety of the first made in Russia alpha, beta long-acting adrenoblocker proxodolol in patients with arterial hypertension of the second degreeS A BelyaevaS A Belyaeva0Research Center for Biomedical technologies, Moscow;"Medsantrud" hospital N 23, MoscowAim. To study efficacy and safety of a new dose and dosage form of proxodolol - a beta-adrenoblocker with alpha1-adrenoblocking activity - in patients with moderate arterial hypertension (AH). Material and methods. A total of 60 patients with verified diagnosis of essential AH of the second degree were randomized into two groups: group 1 (n = 40) received proxodolol, group 2 (n = 20) was given carvedilol. The trial lasted for 89 days. Results. The trial demonstrates that proxodolol is highly effective and safe in the treatment of AH. Conclusion. Proxodolol is effective and safe in hypertension, in a dose 120 mg its activity is the same as carvedilol in a dose 25 mg.https://ter-arkhiv.ru/0040-3660/article/view/30848arterial hypertensionbeta-adrenoblockerscarvedilolproxodolol
spellingShingle S A Belyaeva
S A Belyaeva
Efficacy and safety of the first made in Russia alpha, beta long-acting adrenoblocker proxodolol in patients with arterial hypertension of the second degree
Терапевтический архив
arterial hypertension
beta-adrenoblockers
carvedilol
proxodolol
title Efficacy and safety of the first made in Russia alpha, beta long-acting adrenoblocker proxodolol in patients with arterial hypertension of the second degree
title_full Efficacy and safety of the first made in Russia alpha, beta long-acting adrenoblocker proxodolol in patients with arterial hypertension of the second degree
title_fullStr Efficacy and safety of the first made in Russia alpha, beta long-acting adrenoblocker proxodolol in patients with arterial hypertension of the second degree
title_full_unstemmed Efficacy and safety of the first made in Russia alpha, beta long-acting adrenoblocker proxodolol in patients with arterial hypertension of the second degree
title_short Efficacy and safety of the first made in Russia alpha, beta long-acting adrenoblocker proxodolol in patients with arterial hypertension of the second degree
title_sort efficacy and safety of the first made in russia alpha beta long acting adrenoblocker proxodolol in patients with arterial hypertension of the second degree
topic arterial hypertension
beta-adrenoblockers
carvedilol
proxodolol
url https://ter-arkhiv.ru/0040-3660/article/view/30848
work_keys_str_mv AT sabelyaeva efficacyandsafetyofthefirstmadeinrussiaalphabetalongactingadrenoblockerproxodololinpatientswitharterialhypertensionoftheseconddegree
AT sabelyaeva efficacyandsafetyofthefirstmadeinrussiaalphabetalongactingadrenoblockerproxodololinpatientswitharterialhypertensionoftheseconddegree